Breast cancer 

One of every nine women will develop breast cancer in her lifetime.
Some women are at an increased risk for developing cancer, if they are carriers of hereditary familial genetic mutations. Women diagnosed with breast cancer will most often be treated with a number of drugs from the spectrum available for treatment in clinical oncology: chemotherapy, hormonal manipulations, and advanced biological drugs. Tailoring treatment regimens to each patient must be performed with precision through personalized disease diagnosis. Advantest – Oncotest provides the most up-to-date, comprehensive test battery available for:

·        DNA test to assess the risk of developing the disease.

·    Early detection and disease prevention in women at-risk

·    Guidance in choosing treatment options for all  stages of the disease

·    Personalized treatment in advanced disease settings